Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 1, 2016

View Archived Issues

University of Cape Town researchers identify new antimalarial candidate

Starpharma and AstraZeneca enter drug delivery program collaboration

First patient treated in International Stem Cell's phase I study of ISC-hpNSC stem cell therapy

Bristol-Myers Squibb reviews pipeline highlights of second quarter 2016

Preclinical characterization of M1 allosteric modulator SUVN-I4035 in AD models

Boehringer Ingelheim patents sodium channel blockers

Constellation Pharmaceuticals and Genentech report demethylase 2B inhibitors

Merck & Co. discloses BTK inhibitors

Chengdu Bestchiralbio introduces LDL-receptor expression enhancers

Phase II ECOSPOR study of microbiome therapeutic SER-109 fails to meet primary endpoint

Amgen highlights key events of second quarter 2016

Shire's SHP-626 awarded FDA fast track designation

Merck & Co.'s Zepatier receives marketing authorization in Europe

Sunovion Pharmaceuticals submits NDA for SUN-101/eFlow for COPD

Edge Therapeutics announces treatment of first patient in NEWTON 2 study of EG-1962

EMA accepts for review MAA for sarilumab

Taiho seeks approval of additional indications for Zosyn in Japan

Diamyd Medical signs agreement regarding ongoing GABA/GAD trial

Researchers develop software tool that could facilitate and advance drug development

Increased p-cresyl sulfate level is independent predictor of poor outcome in heart failure

NxGEN MDx and NX Prenatal collaborate on the development of a test to identify preterm birth risk

Setmelanotide as potential novel treatment of proopiomelanocortin deficiency

FDA issues complete response letter for ADMA Biologics' BLA for RI-002

PAF receptor activity could mediate aberrant connectivity in epileptogenesis

GSK and Verily to establish a new bioelectronic medicines company

Therapeutic potential of targeting ADAM33 in asthma

FDA approves Dysport for the treatment of lower limb spasticity in children

Chi-Med and AstraZeneca amend savolitinib codevelopment agreement

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.